Related Experiment Video
Updated: May 17, 2026

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
Cancer stem cells, tumor dormancy, and metastasis
1Department of Pharmacological Sciences, Stony Brook University Stony Brook, NY, USA.
Cancer stem cells (CSCs) explain tumor recurrence and metastasis. Understanding how these cells switch from dormancy to malignancy offers new therapeutic strategies to eliminate metastatic tumors and reduce cancer mortality.
Area of Science:
- Oncology
- Cancer Biology
- Cellular Biology
Background:
- Tumor cells can remain dormant for extended periods before evolving into malignancy.
- The role of cancer stem cells (CSCs) in tumor recurrence, drug resistance, and metastasis is increasingly recognized.
- The transition of cancer cells from dormancy to malignancy is not fully understood.
Purpose of the Study:
- To review current hypotheses linking CSCs and metastasis.
- To summarize mechanisms enabling metastatic CSCs to re-initiate tumors at secondary sites.
- To highlight the importance of understanding CSCs in clinical tumor dormancy and metastasis for developing new therapies.
Main Methods:
- Literature review of existing research on cancer stem cells, metastasis, and tumor dormancy.
- Synthesis of current hypotheses on the CSC-metastasis link.
- Summary of molecular and cellular mechanisms governing metastatic CSC behavior.
Main Results:
- CSCs play a critical role in tumor recurrence, drug resistance, and metastasis.
- Clonal diversity exists within the CSC subpopulation, influencing metastatic potential.
- Specific mechanisms facilitate the ability of metastatic CSCs to establish secondary tumors.
Conclusions:
- Understanding CSCs' contribution to tumor dormancy and metastasis is crucial for effective cancer treatment.
- Targeting CSCs offers a promising therapeutic avenue to eradicate metastatic disease.
- Further research into CSC biology can lead to reduced cancer patient mortality.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
07:18Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...